Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Sundaram Preethi. Officer active across 1 company, notably Catalyst Pharmaceuticals, INC.. Aggregated, 15 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €54k. Activity tracked since 15 September 2022. The latest transaction was disclosed on 15 July 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sundaram Preethi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
54,804 shares@ US$31.50Common Stock, par value $0.001 per shareSEC:0001161697-26-000182:0
6,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000495:0
2,369 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000495:1
6,855 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000449:0
5,603 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000422:0
2,324 shares@ US$26.4111.7% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000189:0
16,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000072:0
6,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000544:0
2,345 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000544:1
6,855 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000507:0
16,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000105:0
6,666 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000652:0
16,666 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000134:0
56,786 shares@ US$5.4975.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000550:0
18,214 shares@ US$5.4924.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000469:0
About Sundaram Preethi
Sundaram Preethi is a declarant linked to Catalyst Pharmaceuticals, INC. on XNAS, where the listed role is Chief Strategy Officer. There are 11 filings in total, and the sampled recent filings cover the period from 2022-09-16 to 2025-12-30, with the modal transaction nature listed as option exercise.